In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
The First Environmental GE Organism Release - almost! Dr. Steven Lindow
New Frontiers in Therapeutic Peptides - Dr. Karsten Eastman
Genetic Variation in Vegetative Propagation - Dr. Danelle Seymour
A Plasmid-Based Cancer Therapy - Dr. Alexander Schneider
Free AI-powered recaps of Talking Biotech with Dr. Kevin Folta and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.